Expression profiles of genes involved in the mouse nuclear factor-kappa B signal transduction pathway are modulated by mangiferin

International Immunopharmacology

Volumn 4, Issue 6, 2004, Pages 763-778

  Leiro, José ^a   Arranz, Juan A ^a   Yáñez, Matilde ^a   Ubeira, Florencio M ^a   Sanmartín, Manuel L ^a   Orallo, Francisco ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Gene and protein arrays; Macrophages; Mangiferin; Mice; NF B signaling pathway

Indexed keywords

CELL ADHESION MOLECULE; COLONY STIMULATING FACTOR 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; MANGIFERIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN C JUN; RANTES; SCAVENGER; SUPEROXIDE; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; APOPTOSIS; ARTICLE; ATHEROMA; CELL ACTIVATION; CELL PROTECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA DAMAGE; DNA HYBRIDIZATION; DRUG ACTIVITY; DRUG EFFECT; FEMALE; GENE EXPRESSION; IMMUNOMODULATION; MACROPHAGE; MONOCYTE; MUTAGENESIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN MICROARRAY; RAT; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION;

ANIMALS; ANTIVIRAL AGENTS; CYTOKINES; DNA; EXUDATES AND TRANSUDATES; FEMALE; GENE EXPRESSION REGULATION; IN SITU HYBRIDIZATION; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; MACROPHAGES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; SIGNAL TRANSDUCTION; THIOGLYCOLATES; XANTHONES;

EID: 2342515281     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2004.03.002     Document Type: Article

References (108)

1. Elenkov I.J., Chrousos G.P. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann. N.Y. Acad. Sci. 966:2002;290-303
2. Forman H.J., Torres M. Redox signaling in macrophages. Mol. Aspects Med. 22:2001;189-216
3. Eliopoulos A.G., Dumitru C.D., Wang C.-C., Cho J., Tsichlis P.N. Induction of COX-2 by LPS in macrophages is regulated by TpI2-dependent CREB activation signals. EMBO J. 21:2002;4831-4840
4. Baldwin A.S. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:1996;649-681
5. Barnes P.J., Karin M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336:1997;1066-1071
6. May M.J., Ghosh S. Signal transduction though NF-κB. Immunol. Today. 19:1998;80-88
7. Li Q., Verma I.M. NF-κB regulation in the immune system. Nat. Rev., Immunol. 2:2002;725-734
8. Baeuerle P.A. The inducible transcription activator NF-kappa B: regulation by distinct protein subunits. Biochim. Biophys. Acta. 1072:1991;63-80
9. Bernier R., Barbeau B., Olivier M., Tremblay M.J. Mycobacterium tuberculosis mannose-capped lipoarabinomannan can induce NF-kappaB-dependent activation of human immunodeficiency virus type 1 long terminal repeat in T cells. J. Gen. Virol. 79:1998;1353-1361
10. Lee S.J., Dimtchev A., Lavin M.F., Dritschilo A., Jung M. A novel ionizing radiation-induced signaling pathway that activates the transcription factor NF-kappaB. Oncogene. 17:1998;1821-1826
11. Mancuso G., Midiri A., Beninati C., Piraino G., Valenti A., Nicocia G., et al. Mitogen-activated protein kinases and NF-kappa B are involved in TNF-alpha responses to group B streptococci. J. Immunol. 169:2002;1401-1409
12. Magnani M., Crinelli R., Bianchi M., Antonelli A. The ubiquitin-dependent proteolytic system and other potential targets for the modulation of nuclear factor-κB (NF-κB). Curr. Drug Targets. 1:2000;387-399
13. García D., Delgado R., Ubeira F.M., Leiro J. Modulation of rat macrophage function by the Mangifera indica L. extracts and mangiferin. Int. Immunopharmacol. 2:2002;797-806
14. Leiro J., Álvarez E., Arranz J.A., González-Siso I., Orallo F. In vitro effects of mangiferin on superoxide concentrations and expression of the inducible nitric oxide synthase, tumour necrosis factor-α and transforming growth factor-β genes. Biochem. Pharmacol. 65:2003;1361-1371
15. Canty T.G., Boyle E.M., Farr A., Morgan E.N., Verrier D.E., Pohlman T.H. Oxidative stress induces NF-κB nuclear translocation without degradation of IκBα Circulation. 100:1998;11361-11364
16. Guha M., Bai W., Nadler J.L., Natarajan R. Molecular mechanisms of tumor necrosis factor a gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways. J. Biol. Chem. 275:2000;17728-17739
17. Rahman I. Oxidative stress, transcription factors and chromatin remodelling in lung inflammation. Biochem. Pharmacol. 64:2002;935-942
18. Nakao S., Ogtata Y., Shimizu E., Yamazaki M., Furuyama S., Sugiya H. Tumor necrosis factor alpha (TNF-alpha)-induced prostaglandin E2 release is mediated by the activation of cyclooxygenase-2 (COX-2) transcription via NFkappaB in human gingival fibroblasts. Mol. Cell Biochem. 238:2002;11-18
19. Wang T., Zhang X., Li J.J. The role of NF-kappaB in the regulation of cell stress responses. Int. Immunopharmacol. 2:2002;1509-1520
20. Garg A., Aggarwall B.B. Nuclear transcription factor-kappaB as a target for cancer drug development. Leukemia. 16:2002;1053-1068
21. Palanki M.S. Inhibitors of AP-1 and NF-kappaB mediated transcriptional activation: therapeutic potential in autoimmune diseases and structural diversity. Curr. Med. Chem. 9:2002;219-227
22. Leiro J., Iglesias R., Paramá A., Sanmartín M.L., Ubeira F.M. Respiratory burst response of rat macrophages to microsporidian spores. Exp. Parasitol. 98:2001;1-9
23. Leiro J., Álvarez E., García D., Orallo F. Resveratrol modulates rat macrophage functions. Int. Immunopharmacol. 2:2002;767-774
24. Álvarez E., Leiro J., Orallo F. Effect of (-)-epigallocatechin-3- gallate on respiratory burst of rat macrophages. Int. Immunopharmacol. 2:2002;849-855
25. Antonsson A., Hughes K., Edin S., Grundstrom T. Regulation of c-Rel localization by binding of Ca(+2)/calmodulin. Mol. Cell Biol. 23:2003;1418-1427
26. Bowie A., O'Neill L.A. Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem. Pharmacol. 59:2000;13-23
27. Chen F.E., Gosh G. Regulation of DNA binding by Rel/NF-kappaB transcription factors: structural views. Oncogene. 18:1999;6845-6852
28. Ding A., Hwang S., Lander H.M., Xie Q.W. Macrophages derived from C3H/HeJ (Lpsd) mice respond to bacterial lipopolysaccharide by activating NF-kappaB. J. Leukoc. Biol. 57:1995;174-179
29. Lin Y.L., Lin J.K. (-)-epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB. Mol. Pharmacol. 52:1997;465-472
30. Lin Y.L., Tsai S.H., Lin-Shiau S.Y., Ho C.T., Lin J.K. Theaflavin-3, 3′-digallate from black tea blocks the nitric oxide synthase by down-regulating the activation of NF-kappaB in macrophages. Eur. J. Pharmacol. 367:1999;379-388
31. Pan M.H., Lin-Shiau S.Y., Ho C.T., Lin J.H., Lin J.K. Suppression of lipopolysaccharide-induced nuclear factor-kappaB activity by theaflavin-3, 3′-digallate from black tea and other polyphenols through down-regulation of IkappaB kinase activity in macrophages. Biochem. Pharmacol. 59:2000;357-367
32. Okabe S., Fujimoto N., Sueoka N., Suganuma M., Fujiki H. Modulation of gene expression by (-)-epigallocatechin gallate in PC-9 cells using a cDNA expression array. Biol. Pharm. Bull. 24:2001;883-886
33. Surh Y.J., Chun K.S., Cha H.H., Han S.S., Keum Y.S., Park K.K., et al. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappaB activation. Mutat. Res. 480-481:2001;243-268
34. Nomura Y. NF-kappaB activation and IkappaB alpha dynamism involved in iNOS and chemokine induction in astroglial cells. Life Sci. 68:2001;1695-1701
35. Hawiger J. Innate immunity and inflammation: a transcriptional paradigm. Immunol. Res. 23:2001;99-109
36. Epinat J.C., Gilmore T.D. Diverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathway. Oncogene. 18:1999;6896-6909
37. Anghileri L.J., Thouvenot P. Natural polyphenols-iron interactions: its biological importance. Biol. Trace Elem. Res. 73:2000;251-258
38. Diebolt M., Andriantsitohaina R. Wine polyphenols modulate calcium handling in rat aorta: involvement of nitric oxide pathway. Fundam. Clin. Pharmacol. 16:2002;289-296
39. Rayet B., Gelinas C. Aberrant rel/nfkb genes and activity in human cancer. Oncogene. 18:1999;6938-6947
40. Ruben S.M., Klement J.F., Coleman T.A., Maher M., Chen C.H., Rosen C.A. I-Rel: a novel rel-related protein that inhibits NF-kappa B transcriptional activity. Genes Dev. 6:1992;745-760
41. Ota M., Katsuyama Y., Kimura A., Tsuchiya K., Kondo M., Naruse T., et al. A second susceptibility gene for developing rheumatoid arthritis in human MHC is localized within a 70-kb interval telomeric of the TNF genes in the HLA class III region. Genomics. 71:2001;263-270
42. Antonelli A., Bianchi M., Crinelli R., Gentillini L., Magnani M. Modulation of ICAM-1 expression in ECV304 cells by macrophage-released cytokines. Blood Cells Mol. Dis. 27:2001;978-991
43. van Assche G., Rutgeerts P. Inflamm. Bowel Dis. 8:2002;291-300
44. Bonita R.E., Rose N.R., Rasooly L., Caturegli P., Burek C.L. Adhesion molecules as susceptibility factors in spontaneous autoimmune thyroiditis in the NOD-H2h4 mouse. Exp. Mol. Pathol. 73:2002;155-163
45. Munro J.M. Endothelial-leukocyte adhesive interactions in inflammatory diseases. Eur. Heart J. 14(Suppl. K):1993;72-77
46. Weber C. Involvement of tyrosine phosphorylation in endothelial adhesion molecule induction. Immunol. Res. 15:1996;30-37
47. Paysant J.R., Rupin A., Verbeuren T.J. Effect of NADPH oxidase inhibition on E-selectin expression induced by concomitant anoxia/reoxygenation and TNF-alpha. Endothelium. 9:2002;263-271
48. Cavaillon J.M. Pro-versus anti-inflammatory cytokines: myth or reality. Cell Mol. Biol. 47:2001;695-702
49. Liles W.C. Immunomodulatory approaches to augment phagocyte-mediated host defence for treatment of infectious diseases. Semin. Respir. Infect. 16:2001;11-17
50. Hubel K., Dale D.C., Liles W.C. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma. J. Infect. Dis. 185:2002;1490-1501
51. Chakraborty A., Hentzen E.R., Seo S.M., Smith C.W. Granulocyte colony-stimulating factor promotes adhesion of neutrophils. Am. J. Physiol., Cell Physiol. 284:2003;C103-C110
52. Leizer T., Cebon J., Layton J.E., Hamilton J.A. Blood. 76:1990;1989-1996
53. Scott P. IL12: initiation cytokine for cell-mediated immunity. Science. 260:1993;496-497
54. Trinchieri G. Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv. Immunol. 70:1998;83-243
55. Yamada H., Mizuno S., Sugawara Y. Interferon regulatory factor 1 in mycobacterial infection. Microbiol. Immunol. 46:2002;751-760
56. Schmidt C., Marth T., Witting B.M., Hombach A., Abken H., Stallmach A. Interleukin-12 antagonists as new therapeutic agents in inflammatory bowel disease. Pathobiology. 70:2002;177-183
57. Valente A.J., Graves D.T., Vialle-Valenti C.E., Delgado R., Shwart C.J. Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. Biochemistry. 27:1988;4162-4168
58. Yoshimura T., Robinson E.A., Tanaka S., Appella E., Kuratsu J.L., Leonard E.J. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J. Exp. Med. 169:1989;1449-1459
59. Matsushima K., Larsen C.G., DuBois G.C., Oppenheim J.J. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J. Exp. Med. 169:1989;1485-1490
60. Teuscher C., Butterfield R.J., Ma R.Z., Zachary J.F., Doerge R.W., Blankenhorn E.P. Sequence polymorphisms in the chemokines Scya1 (TCA-3), Scya2 (Monocyte chemottractant protein (MCP)-1), and Scya12 (MCP-5) are candidates for eae7, a locus controlling susceptibility to monophasic remitting/nonrelapsing experimental allergic encephalomyelitis. J. Immunol. 163:1999;2262-2266
61. Lu B., Rutledge B.J., Gu L., Fiorillo J., Lukacs N.W., Kunkel S.L., et al. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med. 187:1998;601-608
62. Van der Meide P.H., Schellekens H. Cytokines and the immune response. Biotherapy. 8:1996;243-249
63. Chancellor-Freeland C., Zhu G.F., Kage R., Beller D.I., Leeman S.E., Black P.H. Substance P and stress-induced changes in macrophages. Ann. N.Y. Acad. Sci. 771:1995;472-484
64. Decker K. The response of liver macrophages to inflammatory stimulation. Keio. J. Med. 47:1998;1-9
65. Wilson M., Reddi K., Henderson B. J. Periodontal. Res. 31:1996;393-407
66. Rudle N.H. Lymphoid neo-organogenesis: lymphotoxin's role in inflammation and development. Immunol. Res. 19:1999;119-125
67. Idriss H.T., Naismith J.H. TNF alpha and the TNF receptor superfamily: structure-function relationship(s). Microsc. Res. Tech. 50:2000;184-195
68. Taki S., Sato T., Ogasawara K., Fukuda T., Sato M., Hida S., et al. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity. 6:1997;673-679
69. Feng C., Watanabe S., Maruyama S., Suzuki G., Sato M., Furuta T., et al. An alternative pathway for type 1 T cell differentiation. Int. Immunol. 11:1999;1185-1194
70. Maruyama S., Sumita K., Shen H., Kanoh M., Xu X., Sato M., et al. Identification of IFN regulatory factor-1 binding site IL-12 p40 gene promoter. J. Immunol. 170:2003;991-997
71. Hurgin V., Novick D., Rubinstein M. The promoter of IL-18 binding protein: activation by an IFN-gamma-induced complex of IFN regulatory factor 1 and CCAAT/enhancer binding protein beta. Proc. Natl. Acad. Sci. U.S.A. 99:2002;16957-16962
72. Lee S.H., Kim J.W., Lee H.W., Cho Y.S., Oh S.H., Kim Y.J., et al. Interferon regulatory factor-1 (IRF-1) is a mediator for interferon-gamma induced attenuation of telomerase activity and human telomerase reverse transcriptase (hTERT) expression. Oncongene. 22:2003;381-391
73. Takuku S., Nakagawa Y., Shimizu M., Norose Y., Maruyama Y., Wakita T., et al. Induction of hepatic injury by hepatitis C virus-specific CD8(+) murine cytotoxic T lymphocytes in transgenic mice expressing the viral structural genes. Biochem. Biophys. Res. Commun. 301:2003;330-337
74. Walters D.M., Breysse P.N., Schofield B., Will-Karp M. Complement factor 3 mediates particulate matter-induced airway hyperresponsiveness. Am. J. Respir. Cell Mol. Biol. 27:2002;413-418
75. Ivkovic S., Kanazir S., Rakic L., Ehrlich M.E., Ruzdijic S. Enhanced serum response element binding activity correlates with down-regulation of c-fos mRNA expression in the rat brain following repeated cortical lesions. Brain Res. Mol. Brain Res. 52:1997;62-70
76. Leinonen E., Hurt-Camejo E., Wiklund O., Hulten L.M., Hiukka A., Taskinen M.R. Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes. Atherosclerosis. 166:2003;387-394
77. Dinkel K., MacPherson A., Sapolski R.M. Novel glucocorticoid effects on acute inflammation in the CNS. J. Neurochem. 84:2003;705-716
78. Westerholm-Ormio M., Garioch J., Ketola Y., Savilahti E. Inflammatory cytokines in small intestinal mucosa of patients with potential coeliac disease. Clin. Exp. Immunol. 128:2002;94-101
79. Poussier P., Ning T., Chen J., Barmejee D., Julius M. Intestinal inflammation observed in IL-2R/IL-2 mutant mice is associated with impaired intestinal T lymphopoiesis. Gastroenterology. 118:2000;880-891
80. Jung Y., Isaacs J.S., Lee S., Trepel J., Liu Z.G., Neckers L. Hypoxia-inducible factor induction by tumor necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappa beta activation. Biochem. J. 370:2003;1101-1107
81. Lien E., Ingalls R.R. Toll-like receptors. Crit. Care Med. 30(1 Suppl.):2002;S1-S11
82. Takeuchi O., Akira S. Toll-like receptors; their physiological role and signal transduction system. Int. Immunopharmacol. 1:2001;625-635
83. Muzio M., Polentarutti N., Bosisio D., Manoj Kumar P.P., Mantovani A. Toll-like receptor family and signalling pathway. Biochem. Soc. Trans. 28:2000;563-566
84. Bauer S., Wagner H. Bacterial CpG-DNA licenses TLR9. Curr. Top Microbiol. Immunol. 270:2002;145-154
85. Akira S. Mammalian toll-like proteins. Curr. Opin. Immunol. 15:2003;5-11
86. Johnson-Pais T.L., Singer F.R., Bone H.G., McMurray C.T., Hansen M.F., Leach R.J. Identification of a novel tandem duplication in exon 1 of TNFRSF11A gene in two unrelated patients with familial expansile osteolysis. J. Bone Miner. Res. 18:2003;376-380
87. Morgan M.J., Thorburn J., Thomas L., Maxwell T., Brothman A.R., Thorburn A. An apoptosis signaling pathway induced by the death domain of FADD selectively kill normal but not cancerous prostate epithelial cells. Cell Death Differ. 8:2001;696-705
88. Adam-Klages S., Schwandner R., Adam D., Kreder D., Bernardo K., Kronke M. Distinct adapter proteins mediate acid versus neutral sphingomyelinase activation through the p55 receptor for tumor necrosis factor. J. Leukoc. Biol. 63:1998;678-682
89. Morgan M., Thorburn J., Pandolfi P.P., Thorburn A. Nuclear and cytoplasmic shuttling of TRADD induces apoptosis via different mechanisms. J. Cell Biol. 157:2002;975-984
90. Wajant H., Henkler F., Scheurich P. The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators. Cell Signal. 13:2001;389-400
91. Wajant H., Scheurich P. Tumor necrosis factor receptor-associated factor (TRAF)2 and its role in TNF signaling. Int. J. Biochem. Cell Biol. 33:2001;19-32
92. Harlin H., Podack E., Boothby M., Alegre M.L. TCR-independent CD30 signaling selectively induces IL-13 production via a TNF receptor-associated factor/p38 mitogen-activated protein kinase-dependent mechanism. J. Immunol. 169:2002;2451-2459
93. Dinarello C.A. Interleukin 18. Methods. 19:1999;121-132
94. Kashiwamura S., Ueda H., Okamura H. Roles of interleukin-18 in tissue destruction and compensatory reactions. J. Immunother. 25(Suppl. 1):2002;S4-S11
95. Moon Y., Pestka J.J. Vomitoxin-induced cyclooxygenase-2 gene expression in macrophages mediated by activation of ERK and p38 but not JNK mitogen-activated protein kinases. Toxicol. Sci. 69:2002;373-382
96. Imai K., Takeshita A., Hanazawa S. TGF-beta inhibits lipopolysaccharide- stimulated activity of c-Jun N-terminal kinase in mouse macrophages. FEBS Lett. 456:1999;375-378
97. Komatsu Y., Shibuya H., Takeda N., Ninomiya-Tsuji J., Yasui T., Miyado K., et al. Targeted disruption of Tab1 gene causes embryonic lethality and defects in cardiovascular and lung morphogenesis. Mech. Dev. 119:2002;239-249
98. Wald D., Commane M., Stark G.R., Li X. IRAK and TAK1 are required for IL-18 mediated signaling. Eur. J. Immunol. 31:2001;3747-3754
99. Sakurai H., Nishi A., Sato N., Mizukami J., Miyoshi H., Sugita T. TAK1-TAB1 fusion protein: a novel constitutively active mitogen-activated protein kinase kinase kinase that stimulates AP-1 and NF-kappaB signaling pathways. Biochem. Biophys. Res. Commun. 297:2002;1277-1281
100. Chariot A., Leonardi A., Muller J., Bonif M., Brown K., Siebenlist U. Association of the adaptor TANK with the y kappa B kinase (IKK) regulator NEMO connects IKK complexes with IKK epsilon and TBK1 kinases. J. Biol. Chem. 277:2002;37029-37036
101. Wang H., Liu F., Millette C.F., Kilpatrick D.L. Expression of a novel, sterol-insensitive form of sterol regulatory element binding protein 2 (SREBP2) in male germ cell suggests important cell- and stage-specific functions for SREBP targets during spermatogenesis. Mol. Cell. Biol. 22:2002;8478-8490
102. Berger A., Cultaro C.M., Segal S., Spiegel S. The potent lipid mitogen sphingosylphosphocholine activates the DNA binding activity of upstream stimulating factor (USF), a basic helix-loop-helix-zipper protein. Biochim. Biophys. Acta. 1390:1998;225-236
103. Steingrimsson E., Tessarollo L., Pathak B., Hou L., Arnheiter H., Copeland N.G., et al. Mitf and Tfe3, two members of the Mitf-Tfe family of bHLH-Zip transcription factors, have important but functionally redundant roles in osteoclast development. Proc. Natl. Acad. Sci. U. S. A. 99:2002;4477-4482
104. Ying X.Y., Gupta K., Han W.P., Levitan E.S., Prochownick E.V. Mmip-2, a novel RING finger protein that interacts with mad members of the Myc oncoprotein network. Oncogene. 18:1999;6621-6634
105. Morii E., Oboki K., Kataoka T.R., Igarashi K., Kitamura Y. Interaction and cooperation of mi transcription factor (MITF) and myc-associated zinc-finger protein-related factor (MAZR) for transcription of mouse mast cell protease 6 gene. J. Biol. Chem. 277:2002;8566-8571
106. Park J.I., Strock C.J., Ball D.W., Nelkin B.D. The Ras/Raf/MEK/ Extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway. Mol. Cell. Biol. 23:2003;543-554
107. Gygi S.P., Rochon Y., Franza B.R., Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol. 19:1999;1720-1730
108. Pocock J., Gomez-Guerrero C., Harendza S., Ayoub M., Hernandez-Vargas P., Zahner G., et al. Differential activation of NF-kappaB, AP-1, and C/EBP in endotoxin-tolerant rats: mechanisms for in vivo regulation of glomerular RANTES/CCL5 expression. J. Immunol. 15(170):2003;6280-6291